Contact Us: 01282 426380
KM Financial Solutions | UPDATE 2-Spark to charge $850,000 per patient for blindness gene therapy
6766
post-template-default,single,single-post,postid-6766,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 2-Spark to charge $850,000 per patient for blindness gene therapy

02 Jan UPDATE 2-Spark to charge $850,000 per patient for blindness gene therapy

Posted at 16:07h in News by
0 Likes
Jan 3 (Reuters) – Spark Therapeutics Inc said on
Wednesday it will charge $850,000 per patient for its
breakthrough gene therapy to treat a rare form of blindness, a
lower than expected price that the company said reflects patient
and insurer concerns about access and cost.

No Comments

Sorry, the comment form is closed at this time.